Logo

GlaxoSmithKline Extends Use of InforSense Platform

Jul 28, 2008
NEW YORK (GenomeWeb News) – InforSense said on Friday that GlaxoSmithKline has signed a contract to continue using the firm’s InforSense platform for another three years.
 
The London-based firm said that around 800 users within the drug giant are currently using the platform, which is a workflow-management software tool.
 
Terms of the deal were not disclosed.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.